Seminars in Oncology Nursing
Volume 22, Supplement 1 , Pages 5-9, February 2006

EGFR as a Target: Rationale for Therapy

  • Debra Wujcik

      Affiliations

    • Corresponding Author InformationAddress correspondence to Debra Wujcik, RN, MSN, AOCN®, Clinical Trials Office, 9th Floor, 1818 Albion St, Nashville, TN 37208

Vanderbilt-Ingram Cancer Center, Nashville, TN

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported in part by a grant from Bristol-Myers Squibb Company.

PII: S0749-2081(06)00033-7

doi:10.1016/j.soncn.2006.01.010

Seminars in Oncology Nursing
Volume 22, Supplement 1 , Pages 5-9, February 2006

Article Tools

* Image Usage & Resolution